- Presseinformation: Fresenius Medical Care
• The Company will set the new standard of care in the U S with the introduction of the 5008X dialysis machine and unveils launch plans June 17, 2025 – Fresenius Medical Care (FME), the world’s leading provider of products and services for people with kidney disease, today unveiled its new FME Reignite strategy
- Fresenius Medical Care Launches its Strategy FME Reignite with . . .
BAD HOMBURG, Germany and LONDON, June 17, 2025 PRNewswire -- Fresenius Medical Care (FME), the world's leading provider of products and services for people with kidney disease, today unveiled
- Fresenius Medical Care Unveils New Strategy Focused on . . . - Benzinga
Fresenius Medical Care outlines new strategy with 5008X machine rollout in the U S , launch of Value-Based Care segment, and cost-saving goals through FME25+ June 17, 2025 1:21 PM 2 min read
- Fresenius Medical Care Reveals FME Reignite Strategy . . . - Nasdaq
June 17, 2025 — 06:03 am EDT Fresenius Medical Care is planning a 30-40 percent dividend payout and will launch a 1 billion euros share buyback program beginning in 2025, to be completed
- Fresenius Medical Care AG (FMS) Unveils Ambitious FME . . . - GuruFocus
Fresenius Medical Care AG (FMS, Financial), the global leader in kidney care products and services, announced its new strategic initiative, FME Reignite, on June 17, 2025 The strategy focuses on value creation through operational excellence, growth and innovation, and cultural transformation
- Fresenius Company Presentation
Fresenius Medical Care dividend; Net debt adjusted for valuation effect of equity-neutral exchangeable bond | 4 Excluding FMC: €205m Before special items; P L growth rates at constant currency (cc) and adjusted for ARG hyperinflation Net income attributable to shareholders of Fresenius SE Co KGaA Cash Flow from continuing operations €0
- Fresenius Medical Care: Margin Expansion Initiatives Highlighted at . . .
On June 17, Fresenius Medical Care held an investor day at which it updated its operating margin goal to the midteens by 2030 from its current goal of 11%-12% in 2025
- Fresenius Medical Care AG Co. KGaA (FME) | Fresenius Medical Care . . .
On June 17, 2025, Fresenius Medical Care AG unveiled a significant financial strategy: a share buyback program totaling EUR 1 billion With finanzwire com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges
|